Pomegranate for Your Cardiovascular Health
Authors:
- Michael AviramMAMichael Aviram
- Mira RosenblatMRMira Rosenblat
Open Access
- 30 April 2013
- journal article
- Published by Rambam Health Corporation in Rambam Maimonides Medical Journal
- Vol. 4 (2) , e0013
Abstract
Pomegranate is a source of some very potent antioxidants (tannins, anthocyanins) which are considered to be also potent anti-atherogenic agents. The combination of the above unique various types of pomegranate polyphenols provides a much wider spectrum of action against several types of free radicals. Indeed, pomegranate is superior in comparison to other antioxidants in protecting low-density lipoprotein (LDL, "the bad cholesterol") and high-density lipoprotein (HDL, "the good cholesterol") from oxidation, and as a result it attenuates atherosclerosis development and its consequent cardiovascular events. Pomegranate antioxidants are not free, but are attached to the pomegranate sugars, and hence were shown to be beneficial even in diabetic patients. Furthermore, pomegranate antioxidants are unique in their ability to increase the activity of the HDL-associated paraoxonase 1 (PON1), which breaks down harmful oxidized lipids in lipoproteins, in macrophages, and in atherosclerotic plaques. Finally, unique pomegranate antioxidants beneficially decrease blood pressure. All the above beneficial characteristics make the pomegranate a uniquely healthy fruit.Keywords
This publication has 60 references indexed in Scilit:
- Statins: Is It Really Time to Reassess Benefits and Risks?New England Journal of Medicine, 2012
- Pleiotropic effects of pitavastatinBritish Journal of Clinical Pharmacology, 2012
- One Enzyme, Two FunctionsJournal of Biological Chemistry, 2010
- Pomegranate juice polyphenols increase recombinant paraoxonase-1 binding to high-density lipoprotein: Studies in vitro and in diabetic patientsNutrition, 2010
- Effects of Consumption of Pomegranate Juice on Carotid Intima–Media Thickness in Men and Women at Moderate Risk for Coronary Heart DiseaseThe American Journal of Cardiology, 2009
- Effects of Pomegranate Juice Consumption on Myocardial Perfusion in Patients With Coronary Heart DiseaseThe American Journal of Cardiology, 2005
- Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophagesThe Journal of Nutritional Biochemistry, 2005
- Repeated Oral Administration of High Doses of the Pomegranate Ellagitannin Punicalagin to Rats for 37 Days Is Not ToxicJournal of Agricultural and Food Chemistry, 2003
- Why a pomegranate?BMJ, 2000
- Quantitative determination of the polyphenolic content of pomegranate peelEuropean Food Research and Technology, 1996